Attenuation of neuroinflammatory responses and behavioral deficits by Ligusticum officinale (Makino) Kitag in stimulated microglia and MPTP-induced mouse model of Parkinson׳s disease

Dec 3, 2014Journal of ethnopharmacology

Ligusticum officinale may reduce brain inflammation and behavior problems in Parkinson’s disease models

AI simplified

Abstract

L. officinale significantly attenuated the LPS-stimulated increase in inflammatory mediators in BV-2 cells.

  • Inhibition of nuclear factor-kappa beta activation was observed, along with blocking the degradation of IκB-α in BV-2 cells.
  • L. officinale suppressed the phosphorylation of p38-mitogen-activated protein kinase in response to LPS.
  • The extract exhibited antioxidant properties by inhibiting free radicals.
  • Prophylactic treatment with L. officinale in a mouse model of Parkinson's disease prevented microglial activation and improved behavioral outcomes.
  • HPLC analysis identified ferulic acid as a major component of L. officinale, which also inhibited proinflammatory mediator release.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free